Monday, June 04, 2007 8:34:31 PM
Recent VIR News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:28:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 12:10:48 PM
- Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer • Business Wire • 09/10/2024 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2024 08:29:38 PM
- Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers • Business Wire • 09/09/2024 08:05:00 PM
- Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • Business Wire • 08/22/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:43:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:08:53 PM
- Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities • Business Wire • 08/01/2024 08:02:00 PM
- Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers • Business Wire • 08/01/2024 08:01:00 PM
- Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 • Business Wire • 07/18/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 08:40:36 PM
- Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection • Business Wire • 06/26/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 08:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 10:04:32 AM
- Tobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment • Business Wire • 06/05/2024 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 04:13:41 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 03:57:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 06:43:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 06:42:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:06:02 PM
- Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 05/29/2024 08:05:00 PM
- Vir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as Chief Medical Officer • Business Wire • 05/29/2024 12:05:00 PM
- Vir Biotechnology to Host 2024 Annual Meeting of Stockholders • Business Wire • 05/23/2024 08:05:00 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM